Abstract
Unlike peripheral nervous system neurons and certain groups of nerve cells in the CNS, cortical projection neurons are tolerant of axonal lesions. This resistance is incongruent with the massive death of pyramidal neurons in age-associated neurodegenerative diseases that proceed along corticocortical connections. Some insights have emerged from our previous work showing that pyramidal cells in piriform cortex undergo classical apoptosis within 24 h after bulbectomy via transsynaptic, but not retrograde, signaling. These findings allow the investigation of cellular and molecular changes that take place in the context of experimental cortical degeneration. In the present study, we show that the transsynaptic death of pyramidal neurons in piriform cortex is a nitric oxide-mediated event signaled by activated interneurons in layer I. Thus, we demonstrate that cortical interneurons play an essential role in transducing injury to apoptotic signaling that selectively targets pyramidal neurons. We propose that this mechanism may be generic to cortical degenerations and amenable to therapeutic interventions.
Studies of neuronal injury and death in the peripheral nervous system (PNS) have been greatly facilitated with the use of simple lesion models, i.e., axotomy, after which motor, sensory, and sympathetic neurons undergo stereotypical retrograde alterations, sometimes progressing to cell death (1, 2). The vulnerability of PNS neurons to axotomy is presumably related to the deprivation of target-derived trophic signals (3–6). In the CNS, the vulnerability of projection neurons to separation from targets is variable. Cortical neurons in particular are viewed as tolerant of axonal lesions (2). This tolerance to injury is puzzling in view of the massive death of cortical pyramidal cells in age-associated neurodegenerative diseases, a phenomenon that appears to follow patterns of corticocortical connectivity (7, 8). Our previous efforts to comprehend the surprising tolerance of cortical neurons to experimental lesions led to the characterization of an experimental model of cortical degeneration in which pyramidal neurons in piriform cortex are vulnerable to ablations of the olfactory bulb (9). In this setting, pyramidal cells undergo classical apoptosis within 24 h after bulbectomy via transsynaptic, but not retrograde, signaling. The lesion effect is powerful, but specific to relay pyramidal neurons located superficially in layer II, in a pattern contrasting the nonselective death of cortical neurons in classical anoxic–ischemic injury. These findings allow the investigation of molecular and cellular changes that take place in the context of transsynaptic cell death, a mechanism speculated to underlie cell death in neurodegenerative disorders involving the cerebral cortex, such as Alzheimer's disease (7, 10, 11).
In the present study, we use anatomical, pharmacological, and molecular methodologies, including genetically altered (nNOS–/–) mice, to show that the transsynaptic death of pyramidal neurons in piriform cortex is a nitric oxide (NO)-mediated event initiated by activated interneurons, including reactivated Cajal–Retzius cells. This indirect triggering of apoptosis may serve to target cell death signaling selectively to denervated neurons. The efficiency as well as selectivity of this mechanism suggests its broader role in determining a stepwise elimination of cortical relay neurons in neurological injury and age-associated cortical degenerations.
Materials and Methods
Surgical Lesions to Remove Bulb Afferents to Piriform Cortex in Rats and Mice: Bulbotomies and Bulbectomies. To deprive the piriform cortex of afferents from the olfactory bulb while minimizing the direct impact of the lesion, in rats, we modified the original procedure that involved aspiration bulbectomy (9) and performed needle transections of the olfactory peduncle through a craniotomy window centered 1 mm lateral to frontal suture (bulbotomies). In the mouse, a portion of the primary olfactory bulb is located underneath the frontal pole and, in many cases, immediately adjacent to the rostral piriform cortex; in addition, the olfactory peduncle is situated immediately dorsal to the carotid siphon, and needle manipulations often cause strokes in the territory of the middle cerebral artery. For these reasons, mice were subjected to unilateral aspiration lesions of the bulb after wide paramesial craniotomy at the level of the frontal suture.
Histochemistry and Immunocytochemistry (ICC) for Markers of Normal and Injured/Apoptotic Piriform Cortical Neurons. For histochemical and ICC studies, rats (Sprague–Dawley, male, 250–300 g) were killed at 6, 8, 10, 14, and 20 h after bulbotomy with 3% neutral-buffered paraformaldehyde, and brain blocks containing the entire forebrain were obtained as described (12). In exception to this rule, tissues intended for citrulline ICC were derived from animals perfused with 5% glutaraldehyde/0.5% paraformaldehyde (13). Antibodies and procedures are detailed in Supporting Text, which is published as supporting information on the PNAS web site. NADPH diaphorase (NADPHd) histochemistry was performed according to Vincent et al. (14). Reelin ICC used the well characterized monoclonal antibody CR-50 (a gift from Kazunori Nakajima, Jikei University, Tokyo). Citrulline ICC used a rabbit antiserum (courtesy of Solomon H. Snyder, The Johns Hopkins Medical School). To study the direct innervation of layer I interneurons by olfactory bulb afferents, we injected the anterograde tracer biotin dextran amine in the olfactory bulb of normal rats. Surgical and histological procedures for the visualization of olfactory bulb terminals in piriform cortex are described in Supporting Text.
In Situ Hybridization (ISH) for Immediate Early Gene Induction in Piriform Cortex After Bulbotomy. RNA sense and antisense probes for c-fos and c-jun were prepared essentially as described (15) and detailed in Supporting Text. ISH used freshly frozen coronal sections through the piriform cortex of bulbotomized rats killed at 6, 8, 10, 14, and 20 h after lesion and was performed as per standard protocols in our laboratory (15).
Conventional Histology/Cell Counts on Lesioned WT and nNOS–/– Mice. Mice (8 WT, 11 nNOS–/–) generated as described (16) were subjected to unilateral bulbectomy. Twenty-four hours after the lesion, animals were killed with neutral-buffered 4% paraformaldehyde. Brain tissues were prepared for stereological counts of normal and apoptotic neurons in piriform cortex by using the optical fractionator probe (17) as detailed in Supporting Text.
Pharmacological Inhibition of Neuronal NO Synthase (nNOS). Rats (Sprague–Dawley, male, 250–300 g) were subjected to unilateral bulbotomy or sham operation and treated with the specific nNOS inhibitor 3-bromo-7-nitroindazole (3BR-7NI) (A. G. Scientific, San Diego) in DMSO in two doses given i.p. at the time of lesion and 6 h after surgery. Subjects were divided into five groups, i.e., sham, vehicle, and three dose regimens of 3BR-7NI (60, 20, and 10 mg/kg, n = 5 in each group). Animals were killed with neutral-buffered 4% paraformaldehyde 24 h after bulbotomy, and tissues were prepared for stereological counts of apoptotic cells in layer II of olfactory cortex as described in Supporting Text.
Stereological Assessment of nNOS/NADPHd(+) Fibers in Layer I of Deafferented Piriform Cortex. NADPHd-stained, systematically selected serial sections through the anterior piriform cortex of bulbotomized or sham-operated rats killed at 8, 14, and 20 h after lesion were analyzed for the areal fraction of nitrinergic fibers in layer I (18) as detailed in Supporting Text.
Characterization of Apoptosis in Piriform Cortex: Terminal Deoxynucleotidyltransferase-Mediated dUTP Nick End Labeling (TUNEL) and DNA Gels. TUNEL was performed essentially as described (19) on dry premounted sections from bulbotomized or shamoperated rats 6, 8, 10, 14, and 20 h after lesion. For electrophoresis, DNA was extracted from fresh samples of layer II of piriform cortex at 6, 10, 16, and 22 h after bulbotomy, 33P-endlabeled, and electrophoresed as described (19).
RT-PCR and Real-Time Quantitative RT-PCR for nNOS mRNA. RT-PCR served as a semiquantitative screen for levels of nNOS expression in layer I of piriform cortex 6, 12, 18, and 24 h after bulbotomy or sham surgery. Detailed procedures including primer sequences are described in Supporting Text. Based on the results of screening that suggested an increase in nNOS expression 12 h after bulbotomy, we targeted real-time quantitative RT-PCR analysis of nNOS mRNA to that time point by using iQ SYBR Green Supermix (Bio-Rad) (details in Supporting Text). The number of PCR cycles (Ct) needed to reach a threshold level of SYBR Green fluorescence corresponding to the linear range of amplification was further normalized by subtracting the Ct for the housekeeping gene GAPDH (ΔCt = Ct nNOS – Ct GAPDH). Final outcome was expressed as sham or bulbotomy group difference from the unlesioned group (ΔΔCt).
Western Blotting for Neuronal/Inducible/Endothelial NOS, Poly(ADP-Ribose) Polymerase (PARP), Bax, and Protein Carbonylation. Bulbotomized or sham-operated rats were killed by decapitation 6, 12, 18, or 24 h after lesion, and protein samples from layer I or layer II were separately analyzed for nNOS, inducible NOS, and endothelial NOS (layer I) or PARP and bax (layer II) as described in Supporting Text.
Results
Early Signaling in Deafferented Piriform Cortex Is an Event Extrinsic to Degenerating Neurons: The Transsynaptic Activation of nNOS-Expressing Interneurons of Layer I. Ablations of the olfactory bulb cause transsynaptic death of 53,400 neurons in layer IIα of the corresponding idiotypic sensory (piriform) cortex (9). To confirm that bulbotomies have the same transsynaptic effect, we studied TUNEL-stained sections 6, 8, 10, 14, and 20 h after lesion. Staining of condensed/fragmented nuclei appeared in layer IIα by 14 h and became intense at 20 h; these results validate that bulbotomy lesions used in this study are indistinguishable from bulbectomies in causing transsynaptic apoptosis of semilunar pyramids of layer IIα (Fig. 1 A and B).
Immediate early gene (c-fos and c-jun) ICC and ISH were used to screen for cellular activation in piriform cortex before the apoptotic peak, i.e., 6–20 h after bulbotomy. Remarkably, little or no change was seen in layer IIα. The greatest activation was observed in interneurons and astrocytes in the external half of layer I (Iα) and was evident 10–14 h after lesion (Fig. 1 C and D and Fig. 8, which is published as supporting information on the PNAS web site). Dual-label ICC for c-fos and 2′,3′-cyclic nucleotide 3′-phosphodiesterase or c-fos and myelin basic protein (MBP) (for immature and mature oligodendrocytes, respectively) or c-fos and the microglial marker OX-42 (for microglia) did not produce double-labeled profiles up to 14 h after bulbotomy.
Consistent with the activation of layer Iα, NADPHd histochemistry/nNOS ICC revealed a population of interneurons in proximity to the lateral olfactory tract, evident only in bulbotomized animals (Fig. 2 A–D). These layer-Iα interneurons become apparent 10 h after lesion and continue to be highly reactive for NADPHd/nNOS at 20 h. The presence of citrulline immunoreactivity in these neurons 14 and 20 h after lesion (Fig. 2C Inset) indicates that nNOS induction is associated with the release of NO. The absence of TUNEL staining in layer Iα up to 48 h after lesion indicates that bulbotomy does not cause the degeneration of layer Iα interneurons. At least part of the cause for the persistence of these cells may be the expression of manganese superoxide dismutase (MnSOD) evident at 14 and 20 h after lesion, but not at earlier time points or in sham-operated animals (Fig. 2E) (20, 21).
Most NADPHd/nNOS reactivity in piriform cortex is localized in the axons of layer Iα interneurons that branch extensively throughout layer I (Figs. 2 C and D and 3A). Stereological counts of these axons show an increase at 8 h after lesion with a further significant increment at 20 h (Fig. 3B). The rapidity of this response indicates nNOS overexpression, rather than de novo axonal branching. This prediction is consistent with increased perikaryal nNOS staining in layer I and is confirmed with nNOS expression screening by semiquantitative RT-PCR or Western blotting at different time points after lesion. By both analyses, nNOS mRNA and protein progressively increased in layer I beginning at 12 h after bulbotomy. By real-time RT-PCR, nNOS mRNA increased 2.5-fold compared to unlesioned piriform cortex at 12 h; this difference is significant when we consider the lack of change in sham-operated animals (Fig. 3C). No changes were found in the expression of inducible and endothelial NOS by Western screening up to 20 h after lesion.
nNOS Gene Deletion or Pharmacological Inhibition Rescues Neurons in Piriform Cortex from Transsynaptic Degeneration. To assess the significance of nNOS up-regulation for the apoptotic outcome of bulbotomy, we examined the effect of suppressing nNOS activity by gene ablation or pharmacological inhibition of the enzyme on numbers of dying neurons. nNOS–/– and WT mice were subjected to aspiration bulbectomies (Fig. 4A), and numbers of total neurons in layers I–II of anterior piriform cortex as well as numbers of apoptotic profiles were counted with stereological methods (Fig. 4 A and B). Twenty-four hours after bulbectomy, we detected ≈6,000 apoptotic profiles (corresponding to ≈6% of layer I–II neurons) in the piriform cortex of WT animals; in nNOS-null mice, we counted ≈2,500 apoptotic profiles (corresponding to ≈2% of layer I–II neurons), i.e., a significant reduction by 3,500 profiles when compared to WT littermates (Fig. 4 C and D). Inhibition of nNOS activity by the nNOS-specific compound 3BR-7NI in doses that result in near total blockade of the enzyme in the brain (Fig. 5 Upper) ameliorated transsynaptic apoptosis in piriform cortex. Doses in the range of 20–60 mg/kg were particularly effective (Fig. 5 Lower).
nNOS Induction in Deafferented Piriform Cortex Is Associated with Downstream Signaling Consistent with NO-Mediated Cell Death. To confirm the suggestion that NO is a critical upstream signal for the activation of apoptosis in layer II neurons, we processed microdissected samples of layer II for DNA fragmentation, markers of oxidative-free radical injury, and the expression/processing of proteins known to execute downstream steps in NO-mediated cell death (Fig. 6). DNA electrophoresis showed some oligonucleosomal fragmentation at 16 h and was robust by 22 h (Fig. 6A). Protein oxidative damage as shown by excessive carbonylation was an earlier event, beginning at 10 h and becoming intense by 12 h (Fig. 6B). At 12 h after bulbotomy (i.e., a time point coinciding with increased nNOS expression in layer I), Western blotting showed PARP cleavage to p85 and upregulation of bax (Fig. 6C). The latter was confirmed with ICC 14 and 20 h after bulbotomy (Fig. 6D). At 20 h, many neurons in layer IIα also stained with antibodies specific for active caspase 3 (Fig. 6E). These observations divulge key events critical for the mediation of NO-induced cell death, i.e., downstream oxidative injury including DNA damage to vulnerable neurons and further downstream cytosolic activation of proteins of the caspase and bcl-2 family. These events occur at times compatible with their role in the apoptosis of layer II neurons.
Layer I Piriform Neurons Activated by Bulb Lesions Are Reelin(+) Interneurons. The implication of interneurons in the initial signaling of transsynaptic apoptosis of pyramidal neurons in piriform cortex raises further questions about the identity of these cells and their role in the regulation of cortical cell number. nNOS expression in layer I is developmentally related to Cajal–Retzius cells, the first postmitotic neurons of cerebral cortex that die or become dormant after the completion of cortical development (22, 23). To explore the hypothesis that Cajal–Retzius or phenotypically related cells become reactivated after lesions of the mature piriform cortex, we stained sections through the piriform cortex of lesioned or sham animals with the monoclonal antibody CR-50 directed against the glycoprotein reelin, a specific marker of Cajal–Retzius cells (24). In normal animals, many CR-50(+) cells were seen in the outer portions of piriform cortex embedded in a reelin-rich neuropil that precisely delineated layer Iα (Fig. 7A). Based on dual ICC for c-fos and CR-50, reelin(+) neurons are activated 10–14 h after bulbotomy, i.e., coinciding with the general induction of cells in layer Iα after bulb lesions (Fig. 9, which is published as supporting information on the PNAS web site). Dual-label ICC for CR-50 and nNOS showed that, 10–14 h after bulbotomy, almost all reelin(+) cells in layer I are also reactive for nNOS (Fig. 7 B–D). At least half of neurons dually labeled for CR-50 and nNOS have the cytological features of Cajal–Retzius cells (Fig. 7 B–D). Besides reelin, Cajal–Retzius cells express calcium binding proteins and γ-aminobutyric acidergic neurotransmitter markers in various degrees and stages of development (22, 25). Dual ICC for nNOS or reelin with calbindin, calretinin, and glutamic acid decarboxylase (GAD) 14 h after bulbotomy reveals a 50% colocalization between nNOS and GAD, but not nNOS/reelin and calbindin or nNOS/reelin and calretinin in layer I neurons (Fig. 10, which is published as supporting information on the PNAS web site).
The early activation of reelin(+) interneurons in the mature piriform cortex after bulbotomy is made possible via their direct innervation from mitral cell axons that are transected with this lesion. In anterograde labeling experiments using the axonal marker biotin dextran amine combined with CR-50 ICC, we found synaptic boutons from mitral cell axons apposed to the cell bodies of reelin(+) neurons in confocal microscopic analysis followed by three-dimensional reconstruction (Fig. 11, which is published as supporting information on the PNAS web site).
Discussion
Taken together, the findings of this study indicate that transsynaptic apoptosis of pyramidal neurons in piriform cortex is signaled by inducible inhibitory interneurons. First, we have shown the induction of nNOS expression in a subset of layer I interneurons 6–8 h before the apoptotic death of pyramidal neurons. Second, we have shown that nNOS gene deletion or pharmacological inhibition rescues a substantial number of pyramidal neurons from transsynaptic degeneration, a pattern suggesting that NO released by layer I interneurons is a critical upstream signal for the initiation of apoptosis. This contention is consistent with the absence of early activation, after bulbotomy, of other cells known to initiate or mediate neuronal cell death, such as phagocytic microglia (9) and the generally accepted role of NO in signaling neuronal apoptosis (26, 27). The role of NO as an apoptotic signal in the bulbotomy model is further supported by our molecular studies on microdissected samples of layer II that reveal cellular and molecular events consistent with the downstream execution of NO-mediated cell death. Third, we have generated some insights into the identity of layer I interneurons implicated in the triggering of transsynaptic apoptosis. These nerve cells express phenotypic markers (e.g., reelin and GAD) and have the cytological features of inhibitory cortical interneurons, possibly including dormant Cajal–Retzius cells. The direct recipients of olfactory bulb axons, these interneurons are induced, by anterograde signals related to bulbotomy, to synthesize and release NO via a dense plexus of axonal branches. Volume signaling models of release and passive diffusion of NO predict an idealized circular target area with a 100-μm radius (28, 29), i.e., within reach for neurons located superficially, but not deeply, in layer II. Although the selective degeneration of layer IIα neurons may be the mere effect of proximity to NO-releasing interneurons, we cannot rule out the contribution of signals from degenerating terminals of mitral cell axons apposed directly to the distal dendrites of layer IIα neurons or the deprivation of anterogradely transported trophic factors, e.g., brain-derived neurotrophic factor. Together, these mechanisms may serve to eliminate cortical projection neurons that, for whatever reason, are excluded from functional circuits. The activation of small nNOS(+) interneurons may be implicated in the mediation of cortical apoptosis in models beyond deafferentation, such as N-methyl-d-aspartate antagonist-induced apoptosis of pyramidal neurons in piriform cortex and elsewhere.**
Death of cortical neurons by transsynaptic apoptosis and NO-induced necrosis in models of anoxic injury/stroke appear to involve similar downstream cellular steps except that, in the former, levels of superoxide anion may not be as elevated as in the latter (27). This difference may determine the type of cell death, with apoptosis predominating in transsynaptic injury and necrosis prevailing in models of stroke. However, what is qualitatively unique about transsynaptic cortical cell death compared to anoxic/ischemic injury is the delegation of the injurious role to a set of cortical interneurons, rather than a direct effect via N-methyl-d-aspartate receptors (26). Certain populations of cortical interneurons may serve to both amplify the transsynaptic effect and target it to a select population of cortical projection neurons. This cellular model accounts for a more controlled, selective death of cortical neurons. However, if the initial injury signals persist, apoptosis may be further propagated in the anterograde fashion via corticocortical connections. This model predicts a higher risk for cortical neurons with reciprocal connections and multiple convergent afferent inputs, i.e., neurons of associative cortices and of entorhinal cortex, as it is encountered in age-associated degenerations of the cerebral cortex.
Supplementary Material
Acknowledgments
This work was supported by National Institutes of Health Grant RO1 AG16263.
This paper was submitted directly (Track II) to the PNAS office.
Abbreviations: ICC, immunocytochemistry; NADPHd, NADPH diaphorase; ISH, in situ hybridization; NOS, nitric oxide synthase; nNOS, neuronal NOS; 3BR-7NI, 3-bromo-7-nitroindazole; TUNEL, terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling; PARP, poly(ADP-ribose) polymerase.
Footnotes
Welsh, A. M. & Koliatsos, V. E. (2003) Soc. Neurosci. Abstr., p. 29 (abstr.).
References
- 1.Snider, W. D., Elliott, J. L. & Yan, Q. (1992) J. Neurobiol. 23, 1231–1246. [DOI] [PubMed] [Google Scholar]
- 2.Koliatsos, V. E. & Price, D. L. (1996) Brain Pathol. 6, 447–465. [DOI] [PubMed] [Google Scholar]
- 3.Hamburger, V., Brunso-Bechtold, J. K. & Yip, J. W. (1981) J. Neurosci. 1, 60–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Johnson, E. M., Jr. (1978) Brain Res. 141, 105–118. [DOI] [PubMed] [Google Scholar]
- 5.Oppenheim, R. W., Maderdrut, J. L. & Wells, D. J. (1982) J. Comp. Neurol. 210, 174–189. [DOI] [PubMed] [Google Scholar]
- 6.Ehlers, M. D., Kaplan, D. R., Price, D. L. & Koliatsos, V. E. (1995) J. Cell Biol. 130, 149–156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hof, P. R. & Morrison, J. H. (1994) in Alzheimer Disease, eds. Terry, R. D., Katzman, R. & Bick, K. L. (Raven, New York), pp. 197–229.
- 8.Troncoso, J. C., Sukhov, R. R., Kawas, C. H. & Koliatsos, V. E. (1996) J. Neuropathol. Exp. Neurol. 55, 1134–1142. [DOI] [PubMed] [Google Scholar]
- 9.Capurso, S. A., Calhoun, M. E., Sukhov, R. R., Mouton, P. R., Price, D. L. & Koliatsos, V. E. (1997) J. Neurosci. 17, 7372–7384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Braak, H. & Braak, E. (1990) in Alzheimer's Disease, eds. Maurer, K., Riederer, P. & Beckmann, H. (Springer, New York), pp. 85–91.
- 11.Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R. & Van Hoesen, G. W. (1991) Cereb. Cortex 1, 103–116. [DOI] [PubMed] [Google Scholar]
- 12.Koliatsos, V. E., Price, D. L., Gouras, G. K., Cayouette, M. H., Burton, L. E. & Winslow, J. W. (1994) J. Comp. Neurol. 343, 247–262. [DOI] [PubMed] [Google Scholar]
- 13.Eliasson, M. J., Huang, Z., Ferrante, R. J., Sasamata, M., Molliver, M. E., Snyder, S. H. & Moskowitz, M. A. (1999) J. Neurosci. 19, 5910–5918. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Vincent, S. R., Johansson, O., Hokfelt, T., Skirboll, L., Elde, R. P., Terenius, L., Kimmel, J. & Goldstein, M. (1983) J. Comp. Neurol. 217, 252–263. [DOI] [PubMed] [Google Scholar]
- 15.Koliatsos, V. E., Price, D. L., Clatterbuck, R. E., Markowska, A. L., Olton, D. S. & Wilcox, B. J. (1993) Ann. N.Y. Acad. Sci. 695, 292–299. [DOI] [PubMed] [Google Scholar]
- 16.Huang, P. L., Dawson, T. M., Bredt, D. S., Snyder, S. H. & Fishman, M. C. (1993) Cell 75, 1273–1286. [DOI] [PubMed] [Google Scholar]
- 17.West, M. J., Slomianka, L. & Gundersen, H. J. G. (1991) Anat. Rec. 231, 482–497. [DOI] [PubMed] [Google Scholar]
- 18.Vehmas, A. K., Kawas, C. H., Stewart, W. F. & Troncoso, J. C. (2003) Neurobiol. Aging 24, 321–331. [DOI] [PubMed] [Google Scholar]
- 19.Liu, Z., Gastard, M., Verina, T., Bora, S., Mouton, P. R. & Koliatsos, V. E. (2001) J. Comp. Neurol. 441, 1–8. [DOI] [PubMed] [Google Scholar]
- 20.Keller, J. N., Kindy, M. S., Holtsberg, F. W., St. Clair, D. K., Yen, H. C., Germeyer, A., Steiner, S. M., Bruce-Keller, A. J., Hutchins, J. B. & Mattson, M. P. (1998) J. Neurosci. 18, 687–697. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Gonzalez-Zulueta, M., Ensz, L. M., Mukhina, G., Lebovitz, R. M., Zwacka, R. M., Engelhardt, J. F., Oberley, L. W., Dawson, V. L. & Dawson, T. M. (1998) J. Neurosci. 18, 2040–2055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Marin-Padilla, M. (1998) Trends Neurosci. 21, 64–71. [DOI] [PubMed] [Google Scholar]
- 23.Santacana, M., Uttenthal, L. O., Bentura, M. L., Fernandez, A. P., Serrano, J., de Velasco, J. M., Alonso, D., Martinez-Murillo, R. & Rodrigo, J. (1998) Dev. Brain Res. 111, 205–222. [DOI] [PubMed] [Google Scholar]
- 24.Ogawa, M., Miyata, T., Nakajima, K., Yagyu, K., Seike, M., Ikenaka, K., Yamamoto, H. & Mikoshiba, K. (1995) Neuron 14, 899–912. [DOI] [PubMed] [Google Scholar]
- 25.Meyer, G., Goffinet, A. M. & Fairen, A. (1999) Cereb. Cortex 9, 765–775. [DOI] [PubMed] [Google Scholar]
- 26.Lipton, S. A., Choi, Y.-B., Pan, Z.-H., Lei, S. Z., Chen, H.-S. V., Sucher, N. J., Loscalzo, J., Singel, D. J. & Stamler, J. S. (1993) Nature 364, 626–632. [DOI] [PubMed] [Google Scholar]
- 27.Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P. & Lipton, S. A. (1995) Proc. Natl. Acad. Sci. USA 92, 7162–7166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Wood, J. & Garthwaite, J. (1994) Neuropharmacology 33, 1235–1244. [DOI] [PubMed] [Google Scholar]
- 29.Philippides, A., Husbands, P. & O'Shea, M. (2000) J. Neurosci. 20, 1199–1207. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.